ESR1 and cancer: Based on the drug information, 29 sex-biased mRNAs were drug-targeted genes and six (CD38, PGR, ESR1, GABRP, F3, PRKCB) of them were targeted by cancer therapeutic drugs (Fig. 7A,Supplementary Table S8).